There may be a relationship between traumatic life event stress and atrial fibrillation in women over the age of 45 years old.
The vulnerability is associated with using an internet connection to update software between the Medtronic CareLink and CareLink Encore Programmers (models 2090 and 29901) and the Medtronic Software Distribution Network (SDN).
Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.
Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation are more likely than European Americans to have a first-degree relative with AF
Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.
Wearing a cardioverter-defibrillator does not reduce arrhythmic death in patients with acute myocardial infarction and an ejection fraction of 35% or less.
Apple's newest Series 4 Watch now comes complete with new health features that American Heart Association President Ivor Benjamin, MD, has called "game changing."
Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.
There is variation in the net clinical benefit of anticoagulants based on variation in published atrial fibrillation stroke rates.
Patients implanted with leadless pacemakers had fewer complications in both short- and midterm events compared with patients who received transvenous pacemakers.
Healthy nonmenopausal women taking oral contraceptives exhibited biomarkers for drug-induced torsade de pointes.
Esmolol Hydrochloride in Sodium Chloride Injection 2500mg/250 mL (10mg/mL) Single-Dose Plastic Bag and 2000mg/100mL (20mg/mL) Single-Dose Plastic Bag, a generic version of Brevibloc (Baxter) now available from Mylan.
The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.
The use of a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome in patients with out-of-hospital cardiac arrest.
The KardiaK Platform works through a deep neural network trained to detect hyperkalemia based on data from electrocardiograms (ECG) similar to those captured by the Company's KardiaMobile and KardiaBand devices.
Patients aged 21 years with Wolff-Parkinson White syndrome are at high risk for a life-threatening event.
The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.
Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.
Black survivors of in-hospital cardiac arrest have lower survival at 1, 3, and 5 years vs whites.
Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.
Nearly half of presumed sudden cardiac deaths are not autopsy-defined sudden arrhythmic deaths.
The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.
Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
Studies comparing MMT to buprenorphine maintenance treatment (BMT) over 5-years found buprenorphine to be a safer drug for opioid maintenance treatment as it had no significant effect on QT prolongation.
Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.
Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.
After a Department of Justice investigation, the rate of noncompliant implantable cardioverter-defibrillator use significantly decreased in the hospital setting.
Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.
Cesium chloride is not approved by the FDA to treat cancer or any other disease.
The Cardiology Advisor Articles
- Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks
- Harvard: Fraudulent Data Found in Publications of Heart Researcher
- Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women
- No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
- Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD
- Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
- Long-Term Exposure to Elevated BP Associated With AS and AR
- Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
- Takotsubo Syndrome Associated With Substantial Morbidity, Mortality
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes
- Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials
- Psoriasis Associated With Clinical Signs of Accelerated Atherosclerosis
- Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
- The Striking Effects of Diversity in Health Care: Improving Patient Outcomes